PL418655A1 - 3,7,11,15-tetramethyl-3-vinylhexadecanoic acid and method for obtaining 3,7,11,15-tetramethyl-3-vinylhexadecanoic acid - Google Patents

3,7,11,15-tetramethyl-3-vinylhexadecanoic acid and method for obtaining 3,7,11,15-tetramethyl-3-vinylhexadecanoic acid

Info

Publication number
PL418655A1
PL418655A1 PL418655A PL41865516A PL418655A1 PL 418655 A1 PL418655 A1 PL 418655A1 PL 418655 A PL418655 A PL 418655A PL 41865516 A PL41865516 A PL 41865516A PL 418655 A1 PL418655 A1 PL 418655A1
Authority
PL
Poland
Prior art keywords
acid
vinylhexadecanoic
tetramethyl
obtaining
formula
Prior art date
Application number
PL418655A
Other languages
Polish (pl)
Other versions
PL230424B1 (en
Inventor
Anna Gliszczyńska
Witold Gładkowski
Marta Świtalska
Joanna Wietrzyk
Original Assignee
Uniwersytet Przyrodniczy we Wrocławiu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Przyrodniczy we Wrocławiu filed Critical Uniwersytet Przyrodniczy we Wrocławiu
Priority to PL418655A priority Critical patent/PL230424B1/en
Publication of PL418655A1 publication Critical patent/PL418655A1/en
Publication of PL230424B1 publication Critical patent/PL230424B1/en

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Zgłoszenie dotyczy kwasu 3,7, 11,15-tetrametylo-3- winyloheksadekanowego, o wzorze 1 oraz sposobu jego otrzymywania. Sposób otrzymywania kwasu 3,7,11,15-tetrametylo-3- winyloheksadekanowego polega na tym, że fitol przeprowadza się w wyniku dwuetapowej reakcji w kwas o wzorze 1. Przedmiotowy związek o wzorze 1, może znaleźć zastosowanie w terapii chorób nowotworowych.The application relates to 3,7, 11,15-tetramethyl-3-vinylhexadecanoic acid of formula 1 and the method of its preparation. The method of obtaining 3,7,11,15-tetramethyl-3-vinylhexadecanoic acid is that the phytol is carried out as a result of a two-step reaction to the acid of formula 1. The subject compound of formula 1 can be used in the therapy of cancer.

PL418655A 2016-09-12 2016-09-12 3,7,11,15-tetramethyl-3-vinylhexadecanoic acid and method for obtaining 3,7,11,15-tetramethyl-3-vinylhexadecanoic acid PL230424B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL418655A PL230424B1 (en) 2016-09-12 2016-09-12 3,7,11,15-tetramethyl-3-vinylhexadecanoic acid and method for obtaining 3,7,11,15-tetramethyl-3-vinylhexadecanoic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL418655A PL230424B1 (en) 2016-09-12 2016-09-12 3,7,11,15-tetramethyl-3-vinylhexadecanoic acid and method for obtaining 3,7,11,15-tetramethyl-3-vinylhexadecanoic acid

Publications (2)

Publication Number Publication Date
PL418655A1 true PL418655A1 (en) 2018-03-26
PL230424B1 PL230424B1 (en) 2018-10-31

Family

ID=61661071

Family Applications (1)

Application Number Title Priority Date Filing Date
PL418655A PL230424B1 (en) 2016-09-12 2016-09-12 3,7,11,15-tetramethyl-3-vinylhexadecanoic acid and method for obtaining 3,7,11,15-tetramethyl-3-vinylhexadecanoic acid

Country Status (1)

Country Link
PL (1) PL230424B1 (en)

Also Published As

Publication number Publication date
PL230424B1 (en) 2018-10-31

Similar Documents

Publication Publication Date Title
ZA202001717B (en) Compounds, salts thereof and methods for treatment of diseases
JOP20190194A1 (en) Dicyclic nucleotides for the treatment of cancer
EA201792613A1 (en) COT MODULATORS AND METHODS OF THEIR APPLICATION
EA201792548A1 (en) 4-HYDROXY-3- (HETEROARIL) PYRIDIN-2-ONE APJ AGONISTS FOR APPLICATION IN THE TREATMENT OF CARDIOVASCULAR DISEASES
MX373154B (en) HETEROCYCLIC COMPOUNDS AS INHIBITORS OF LYSINE-SPECIFIC DEMETHYLASE 1 (LSD1).
MX2015010125A (en) Pyridazinone-amides derivatives.
MX2016002368A (en) Substituted heterocyclic sulfonamide compounds useful as trpa1 modulators.
EA201890752A1 (en) METHOD OF OBTAINING ANTI-FIBER CONNECTIONS
MA40076A (en) Syk inhibitors
MX2016010051A (en) Composition and method for aiding sleep.
PH12018502497A1 (en) Adenosine derivatives for use in the treatment of cancer
EA201691649A1 (en) METHOD OF OBTAINING ANTI-FIBER CONNECTIONS
MX2016006975A (en) Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases.
EA201692525A1 (en) SUBSTITUTED COMPOUNDS [1,2,4] TRIAOSOL AND IMIDAZOL AS FUNGICIDES
MX2017013880A (en) Tetrahydronaphthyridinyl propionic acid derivatives and uses thereof.
MX2018007075A (en) POLYCYCLY COMPOUNDS AS INHIBITORS OF TYROSINE QUINASA BRUTON.
EA201691648A1 (en) METHOD OF OBTAINING ANTI-FIBER CONNECTIONS
NZ736970A (en) Process methods for phosphatidylinositol 3-kinase inhibitors
UA115455C2 (en) A METHOD FOR PREPARING COMPOUNDS FOR CANCER TREATMENT
PH12017500737A1 (en) Kcnq2-5 channel activator
EA201692289A1 (en) SUBSTITUTED [1,2,4] TRIAZOL AND IMIDAZOL COMPOUNDS AS FUNGICIDES
CY1119888T1 (en) METHOD FOR THE PRODUCTION OF XANTHOCHOUMOLIS
EA201690227A1 (en) AZAINDOL COMPOUNDS, THEIR PRODUCTION AND METHODS OF THEIR APPLICATION
MX381478B (en) LIQUID DISPERSANT COMPOSITION FOR PLASTER.
MX2020000873A (en) Isotopically labeled bile acid derivatives.